{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:50:34Z","timestamp":1793573434443,"version":"4.5.0"},"reference-count":42,"publisher":"The Endocrine Society","issue":"3","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"National Institutes of Health Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Patients with mutations of the insulin receptor gene (INSR) have extreme insulin resistance and are at risk for early morbidity and mortality from diabetes complications. A case report suggested that thyroid hormone could improve glycemia in INSR mutation in part by increasing brown adipose tissue (BAT) activity and volume.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine if thyroid hormone increases tissue glucose uptake and improves hyperglycemia in INSR mutation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Single-arm, open-label study of liothyronine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>National Institutes of Health.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Patients with homozygous (n = 5) or heterozygous (n = 2) INSR mutation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>Liothyronine every 8 hours for 2 weeks (n = 7); additional 6 months\u2019 treatment in those with hemoglobin A1c (HbA1c) &amp;gt; 7% (n = 4).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Whole-body glucose uptake by isotopic tracers; tissue glucose uptake in muscle, white adipose tissue (WAT) and BAT by dynamic [18F] fluorodeoxyglucose positron emission tomography\/computed tomography; HbA1c.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was no change in whole-body, muscle, or WAT glucose uptake from baseline to 2 weeks of liothyronine. After 6 months, there was no change in HbA1c (8.3 \u00b1 1.2 vs 9.1 \u00b1 3.0%, P = 0.27), but there was increased whole-body glucose disposal (22.8 \u00b1 4.9 vs 30.1 \u00b1 10.0 \u00b5mol\/kg lean body mass\/min, P = 0.02), and muscle (0.7 \u00b1 0.1 vs 2.0 \u00b1 0.2 \u00b5mol\/min\/100 mL, P &amp;lt; 0.0001) and WAT glucose uptake (1.2 \u00b1 0.2 vs 2.2 \u00b1 0.3 \u00b5mol\/min\/100 mL, P &amp;lt; 0.0001). BAT glucose uptake could not be quantified because of small volume. There were no signs or symptoms of hyperthyroidism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Liothyronine administered at well-tolerated doses did not improve HbA1c. However, the observed increases in muscle and WAT glucose uptake support the proposed mechanism that liothyronine increases tissue glucose uptake. More selective agents may be effective at increasing tissue glucose uptake without thyroid hormone\u2013related systemic toxicity.<\/jats:p>\n                  <jats:p>Clinical Trial Registration Number: NCT02457897; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02457897.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgz079","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T05:38:34Z","timestamp":1570426714000},"page":"e158-e171","source":"Crossref","is-referenced-by-count":14,"title":["Thyroid Hormone Effects on Glucose Disposal in Patients With Insulin Receptor Mutations"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-0987","authenticated-orcid":false,"given":"Yevgeniya S","family":"Kushchayeva","sequence":"first","affiliation":[{"name":"University of South Florida, Diabetes and Endocrinology Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Startzell","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Cochran","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyoung","family":"Auh","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Sekizkardes","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Soldin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy V","family":"Kushchayev","sequence":"additional","affiliation":[{"name":"Department of Radiology, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Dieckmann","sequence":"additional","affiliation":[{"name":"Positron Emission Tomography Department, Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Skarulis","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa","family":"Abdul Sater","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Brychta","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M","family":"Cypess","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chun","family":"Lin","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Lightbourne","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Millo","sequence":"additional","affiliation":[{"name":"Positron Emission Tomography Department, Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7382","authenticated-orcid":false,"given":"Rebecca J","family":"Brown","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"issue":"4","key":"2021122102014134600_CIT0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"2021122102014134600_CIT0002","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2337\/diacare.28.5.1240","article-title":"The use of U-500 in patients with extreme insulin resistance","volume":"28","author":"Cochran","year":"2005","journal-title":"Diabetes Care."},{"issue":"11","key":"2021122102014134600_CIT0003","doi-asserted-by":"crossref","first-page":"E1749","DOI":"10.1210\/jc.2013-2317","article-title":"Metreleptin improves blood glucose in patients with insulin receptor mutations","volume":"98","author":"Brown","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122102014134600_CIT0004","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/jc.2009-0543","article-title":"Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance","volume":"95","author":"Skarulis","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"5 Pt 1","key":"2021122102014134600_CIT0005","first-page":"E681","article-title":"Triiodothyronine increases splanchnic release and peripheral uptake of glucose in healthy humans","volume":"247","author":"Bratusch-Marrain","year":"1984","journal-title":"Am J Physiol."},{"issue":"6","key":"2021122102014134600_CIT0006","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1210\/endo-124-6-2755","article-title":"A rapid, extranuclear effect of 3,5,3\u2019-triiodothyronine on sugar uptake by several tissues in the rat in vivo. Evidence for a physiological role for the thyroid hormone action at the level of the plasma membrane","volume":"124","author":"Segal","year":"1989","journal-title":"Endocrinology"},{"issue":"5","key":"2021122102014134600_CIT0007","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1210\/endo-124-5-2166","article-title":"3,5,3\u2019-Triiodothyronine increases cellular adenosine 3\u2019,5\u2019-monophosphate concentration and sugar uptake in rat thymocytes by stimulating adenylate cyclase activity: studies with the adenylate cyclase inhibitor MDL 12330A","volume":"124","author":"Segal","year":"1989","journal-title":"Endocrinology."},{"issue":"1 Pt 2","key":"2021122102014134600_CIT0008","first-page":"H330","article-title":"Effects of hyperthyroidism on muscle blood flow during exercise in rats","volume":"268","author":"McAllister","year":"1995","journal-title":"Am J Physiol."},{"issue":"5 Pt 1","key":"2021122102014134600_CIT0009","first-page":"E593","article-title":"Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans","volume":"248","author":"Dimitriadis","year":"1985","journal-title":"Am J Physiol."},{"issue":"11","key":"2021122102014134600_CIT0010","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1210\/jc.2011-1329","article-title":"Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine","volume":"96","author":"Celi","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122102014134600_CIT0011","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2265.2009.03700.x","article-title":"The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients","volume":"72","author":"Celi","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021122102014134600_CIT0012","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc19-Srev01","article-title":"Summary of revisions: standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"2021122102014134600_CIT0013","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1172\/JCI95476","article-title":"Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy","volume":"128","author":"Brown","year":"2018","journal-title":"J Clin Invest."},{"key":"2021122102014134600_CIT0014","volume-title":"Isotopic Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis","author":"Wolfe","year":"2005","edition":"2nd ed"},{"issue":"12","key":"2021122102014134600_CIT0015","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s001250100026","article-title":"Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis","volume":"44","author":"Virtanen","year":"2001","journal-title":"Diabetologia."},{"issue":"5","key":"2021122102014134600_CIT0016","doi-asserted-by":"crossref","first-page":"E1122","DOI":"10.1152\/ajpendo.2000.279.5.E1122","article-title":"Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans","volume":"279","author":"Peltoniemi","year":"2000","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"3","key":"2021122102014134600_CIT0017","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021122102014134600_CIT0018","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/jc.2014-4024","article-title":"RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122102014134600_CIT0019","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.ijo.0801656","article-title":"Prediction of energy expenditure in a whole body indirect calorimeter at both low and high levels of physical activity","volume":"25","author":"de Jonge","year":"2001","journal-title":"Int J Obes Relat Metab Disord."},{"key":"2021122102014134600_CIT0020","first-page":"6864","article-title":"Optimizing energy expenditure detection in human metabolic chambers","volume":"2009","author":"Brychta","year":"2009","journal-title":"Conf Proc IEEE Eng Med Biol Soc."},{"issue":"6","key":"2021122102014134600_CIT0021","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/oby.2009.14","article-title":"Body composition measured by dual-energy X-ray absorptiometry half-body scans in obese adults","volume":"17","author":"Rothney","year":"2009","journal-title":"Obesity (Silver Spring)."},{"issue":"10","key":"2021122102014134600_CIT0022","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat Med."},{"issue":"15","key":"2021122102014134600_CIT0023","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N Engl J Med."},{"issue":"1","key":"2021122102014134600_CIT0024","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI112798","article-title":"Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue","volume":"79","author":"Bianco","year":"1987","journal-title":"J Clin Invest."},{"issue":"4","key":"2021122102014134600_CIT0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/EJE-10-0246","article-title":"Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism","volume":"163","author":"Maratou","year":"2010","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021122102014134600_CIT0026","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1210\/jc.2013-2312","article-title":"Hyperthyroidism increases brown fat metabolism in humans","volume":"99","author":"Lahesmaa","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122102014134600_CIT0027","doi-asserted-by":"crossref","first-page":"152850","DOI":"10.4061\/2011\/152850","article-title":"Why can insulin resistance be a natural consequence of thyroid dysfunction?","volume":"2011","author":"Brenta","year":"2011","journal-title":"J Thyroid Res."},{"issue":"2","key":"2021122102014134600_CIT0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/er.2009-0007","article-title":"Molecular aspects of thyroid hormone actions","volume":"31","author":"Cheng","year":"2010","journal-title":"Endocr Rev."},{"issue":"5","key":"2021122102014134600_CIT0029","doi-asserted-by":"crossref","first-page":"C980","DOI":"10.1152\/ajpcell.00305.2008","article-title":"L-Thyroxine vs. 3,5,3\u2019-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"296","author":"Lin","year":"2009","journal-title":"Am J Physiol Cell Physiol."},{"issue":"1","key":"2021122102014134600_CIT0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0006-291X(90)91374-2","article-title":"Increased glucose transporter (GLUT4) protein expression in hyperthyroidism","volume":"171","author":"Casla","year":"1990","journal-title":"Biochem Biophys Res Commun."},{"issue":"10","key":"2021122102014134600_CIT0031","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/diab.43.10.1185","article-title":"Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression","volume":"43","author":"Weinstein","year":"1994","journal-title":"Diabetes."},{"issue":"1","key":"2021122102014134600_CIT0032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/thy.2010.0409","article-title":"T3 rapidly increases SLC2A4 gene expression and GLUT4 trafficking to the plasma membrane in skeletal muscle of rat and improves glucose homeostasis","volume":"22","author":"Brunetto","year":"2012","journal-title":"Thyroid."},{"issue":"6","key":"2021122102014134600_CIT0033","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2362.1997.1380688.x","article-title":"The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats","volume":"27","author":"Dimitriadis","year":"1997","journal-title":"Eur J Clin Invest."},{"issue":"8","key":"2021122102014134600_CIT0034","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/a-0643-4739","article-title":"Altered glucose uptake in muscle, visceral adipose tissue, and brain predict whole-body insulin resistance and may contribute to the development of type 2 diabetes: a combined PET\/MR study","volume":"50","author":"Boersma","year":"2018","journal-title":"Horm Metab Res."},{"issue":"1-3","key":"2021122102014134600_CIT0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0303-7207(92)90241-W","article-title":"Thyroid hormone stimulates glucose transport and GLUT1 mRNA in rat Sertoli cells","volume":"87","author":"Ulisse","year":"1992","journal-title":"Mol Cell Endocrinol."},{"issue":"7","key":"2021122102014134600_CIT0036","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/thy.2011.0422","article-title":"Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3","volume":"22","author":"Teixeira","year":"2012","journal-title":"Thyroid."},{"issue":"2","key":"2021122102014134600_CIT0037","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00441-016-2453-3","article-title":"Regulation of glucose transport by thyroid hormone in rat ovary","volume":"366","author":"Ding","year":"2016","journal-title":"Cell Tissue Res."},{"key":"2021122102014134600_CIT0038","doi-asserted-by":"crossref","first-page":"38124","DOI":"10.1038\/srep38124","article-title":"Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice","volume":"6","author":"Weiner","year":"2016","journal-title":"Sci Rep."},{"issue":"2","key":"2021122102014134600_CIT0039","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/JOE-16-0425","article-title":"Thyroid hormones induce browning of white fat","volume":"232","author":"Mart\u00ednez-S\u00e1nchez","year":"2017","journal-title":"J Endocrinol."},{"issue":"7","key":"2021122102014134600_CIT0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF03348892","article-title":"Effect of insulin treatment on osteocalcin levels in diabetic children and adolescents","volume":"16","author":"Guarneri","year":"1993","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2021122102014134600_CIT0041","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest."},{"key":"2021122102014134600_CIT0042","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fendo.2018.00427","article-title":"3,5-Diiodothyronine: a novel thyroid hormone metabolite and potent modulator of energy metabolism","volume":"9","author":"Senese","year":"2018","journal-title":"Front Endocrinol (Lausanne)."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgz079\/30109439\/dgz079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/3\/e158\/41823493\/jcem_105_3_e158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/3\/e158\/41823493\/jcem_105_3_e158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T02:05:09Z","timestamp":1640052309000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/3\/e158\/5582247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,10,7]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgz079","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2019,10,7]]}}}